204 related articles for article (PubMed ID: 24965710)
1. Role of A20 in interferon-α-mediated functional restoration of myeloid dendritic cells in patients with chronic hepatitis C.
Ma L; Zhou Y; Zhang Y; Li Y; Guo Y; He Y; Wang J; Lian J; Hao C; Moorman JP; Yao ZQ; Zhou Y; Jia Z
Immunology; 2014 Dec; 143(4):670-8. PubMed ID: 24965710
[TBL] [Abstract][Full Text] [Related]
2. Human type 2 myeloid dendritic cells produce interferon-λ and amplify interferon-α in response to hepatitis C virus infection.
Zhang S; Kodys K; Li K; Szabo G
Gastroenterology; 2013 Feb; 144(2):414-425.e7. PubMed ID: 23089201
[TBL] [Abstract][Full Text] [Related]
3. Impaired ability of interferon-alpha-primed dendritic cells to stimulate Th1-type CD4 T-cell response in chronic hepatitis C virus infection.
Miyatake H; Kanto T; Inoue M; Sakakibara M; Kaimori A; Yakushijin T; Itose I; Miyazaki M; Kuzushita N; Hiramatsu N; Takehara T; Kasahara A; Hayashi N
J Viral Hepat; 2007 Jun; 14(6):404-12. PubMed ID: 17501761
[TBL] [Abstract][Full Text] [Related]
4. Monocyte-derived dendritic cells from chronic HCV patients are not infected but show an immature phenotype and aberrant cytokine profile.
Gelderblom HC; Nijhuis LE; de Jong EC; te Velde AA; Pajkrt D; Reesink HW; Beld MG; van Deventer SJ; Jansen PL
Liver Int; 2007 Sep; 27(7):944-53. PubMed ID: 17696933
[TBL] [Abstract][Full Text] [Related]
5. Dominating expression of negative regulatory factors downmodulates major histocompatibility complex Class-II expression on dendritic cells in chronic hepatitis C infection.
Tomer S; Chawla YK; Duseja A; Arora SK
World J Gastroenterol; 2016 Jun; 22(22):5173-82. PubMed ID: 27298560
[TBL] [Abstract][Full Text] [Related]
6. Hepatic enrichment and activation of myeloid dendritic cells during chronic hepatitis C virus infection.
Velazquez VM; Hon H; Ibegbu C; Knechtle SJ; Kirk AD; Grakoui A
Hepatology; 2012 Dec; 56(6):2071-81. PubMed ID: 22711645
[TBL] [Abstract][Full Text] [Related]
7. TLR ligand-dependent activation of naive CD4 T cells by plasmacytoid dendritic cells is impaired in hepatitis C virus infection.
Yonkers NL; Rodriguez B; Milkovich KA; Asaad R; Lederman MM; Heeger PS; Anthony DD
J Immunol; 2007 Apr; 178(7):4436-44. PubMed ID: 17372001
[TBL] [Abstract][Full Text] [Related]
8. IFN-α-based treatment of patients with chronic HCV show increased levels of cells with myeloid-derived suppressor cell phenotype and of IDO and NOS.
Salem ML; Zidan AA; Attia M; El-Naggar RE; Nassef M; Abou El-Azm AR; El-Bate H; Yussif M; Galal S; Abo Senna M; El Demellawy M
Immunopharmacol Immunotoxicol; 2017 Aug; 39(4):188-198. PubMed ID: 28472907
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis C virus-specific T-cell reactivity during interferon and ribavirin treatment in chronic hepatitis C.
Cramp ME; Rossol S; Chokshi S; Carucci P; Williams R; Naoumov NV
Gastroenterology; 2000 Feb; 118(2):346-55. PubMed ID: 10648463
[TBL] [Abstract][Full Text] [Related]
10. mRNA cytokine profile in peripheral blood cells from chronic hepatitis C virus (HCV)-infected patients: effects of interferon-alpha (IFN-alpha) treatment.
Shapiro S; Gershtein V; Elias N; Zuckerman E; Salman N; Lahat N
Clin Exp Immunol; 1998 Oct; 114(1):55-60. PubMed ID: 9764603
[TBL] [Abstract][Full Text] [Related]
11. Differential dysfunction in dendritic cell subsets during chronic HCV infection.
Averill L; Lee WM; Karandikar NJ
Clin Immunol; 2007 Apr; 123(1):40-9. PubMed ID: 17239662
[TBL] [Abstract][Full Text] [Related]
12. Interferon-lambda serum levels in hepatitis C.
Langhans B; Kupfer B; Braunschweiger I; Arndt S; Schulte W; Nischalke HD; Nattermann J; Oldenburg J; Sauerbruch T; Spengler U
J Hepatol; 2011 May; 54(5):859-65. PubMed ID: 21145813
[TBL] [Abstract][Full Text] [Related]
13. Functional impairment of dendritic cells in patients infected with hepatitis C virus genotype 1 who failed peginterferon plus ribavirin therapy.
Liang CC; Liu CH; Lin YL; Liu CJ; Chiang BL; Kao JH
J Med Virol; 2011 Jul; 83(7):1212-20. PubMed ID: 21567425
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis C virus inhibits cell surface expression of HLA-DR, prevents dendritic cell maturation, and induces interleukin-10 production.
Saito K; Ait-Goughoulte M; Truscott SM; Meyer K; Blazevic A; Abate G; Ray RB; Hoft DF; Ray R
J Virol; 2008 Apr; 82(7):3320-8. PubMed ID: 18216090
[TBL] [Abstract][Full Text] [Related]
15. Impaired cytokine response in myeloid dendritic cells in chronic hepatitis C virus infection regardless of enhanced expression of Toll-like receptors and retinoic acid inducible gene-I.
Miyazaki M; Kanto T; Inoue M; Itose I; Miyatake H; Sakakibara M; Yakushijin T; Kakita N; Hiramatsu N; Takehara T; Kasahara A; Hayashi N
J Med Virol; 2008 Jun; 80(6):980-8. PubMed ID: 18428149
[TBL] [Abstract][Full Text] [Related]
16. Monocyte-derived dendritic cells in children with chronic hepatitis C: correlation with interferon and ribavirin therapy.
Khedr MA; E Behairy B; Hussein ME; Marei AM; Nage SA; Zakaria HM
Eur J Gastroenterol Hepatol; 2015 Oct; 27(10):1170-4. PubMed ID: 26148246
[TBL] [Abstract][Full Text] [Related]
17. Attenuated expression of A20 markedly increases the efficacy of double-stranded RNA-activated dendritic cells as an anti-cancer vaccine.
Breckpot K; Aerts-Toegaert C; Heirman C; Peeters U; Beyaert R; Aerts JL; Thielemans K
J Immunol; 2009 Jan; 182(2):860-70. PubMed ID: 19124729
[TBL] [Abstract][Full Text] [Related]
18. Dendritic cell function during chronic hepatitis C virus and human immunodeficiency virus type 1 infection.
Fan Z; Huang XL; Kalinski P; Young S; Rinaldo CR
Clin Vaccine Immunol; 2007 Sep; 14(9):1127-37. PubMed ID: 17634507
[TBL] [Abstract][Full Text] [Related]
19. Assessment of Key Elements in the Innate Immunity System Among Patients with HIV, HCV, and Coinfections of HIV/HCV.
Moradi M; Tabibzadeh A; Javanmard D; Ghorbani S; Bokharaei-Salim F; Keivani H; Khazeni M; Monavari SHR
Curr HIV Res; 2020; 18(3):194-200. PubMed ID: 32209045
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis C virus (HCV) core protein-induced, monocyte-mediated mechanisms of reduced IFN-alpha and plasmacytoid dendritic cell loss in chronic HCV infection.
Dolganiuc A; Chang S; Kodys K; Mandrekar P; Bakis G; Cormier M; Szabo G
J Immunol; 2006 Nov; 177(10):6758-68. PubMed ID: 17082589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
